Doctor William McIntyre

Doctor William McIntyre

Population Health Research Institute, Hamilton (Canada)

Member of:

William is a cardiologist and a native of Fredericton, Canada. He completed Medical School and Internal Medicine Residency at Queen’s University. He completed Adult Cardiology Residency at the University of Manitoba. William is enrolled in the Clinician Investigator Program at McMaster University. He is completing clinical training in arrhythmia and a PhD Health Research Methods. He holds fellowship awards from Canadian Institutes of Health Research (CIHR) and the Canadian Stroke Prevention Intervention Network (C-SPIN). William has published over 75 peer-reviewed articles. His current research program is investigating recurrence rates of Atrial Fibrillation Occurring Transiently with Stress (AFOTS). His research interests include atrial fibrillation – including screening and detection, cardiac devices and methods in randomized clinical trials.

Presentations Articles

Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: Insights from the ARTESiA trial

Event: EHRA 2024

Topic: Oral Anticoagulation

Session: Late-Breaking Science: devices

Access

Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness

Event: EHRA 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation: clinical 1

Access

Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort

Event: EHRA 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation: clinical 1

Access

Catheter ablation for atrial fibrillation in patients with heart failure with reduced versus preserved ejection fraction; a systematic review and meta-analysis

Event: ESC Congress 2023

Topic: Heart Failure in Atrial Fibrillation

Session: Invasive management of atrial fibrillation: ablation and LAA closure

Access

VISION Cardiac Surgery Post-operative AF

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Registries on atrial fibrillation and sudden death

Access

Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT

Event: EHRA 2021

Topic: Epidemiology, Prognosis, Outcome

Session: ePoster session

Access

Incidence and risk of short episodes of atrial fibrillation detected with 14 days of continuous electrocardiographic monitoring

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial Fibrillation ePosters

Access

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Event: EHRA 2019

Topic: Rhythm Control, Cardioversion

Session: Moderated ePosters 11: AF: stroke and anticoagulation

Access

Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis

Event: ESC Congress 2018

Topic: Cardioversion and Defibrillation

Session: Atrial fibrillation - General 2

Access

Doctor William McIntyre

Biography

Contributor content

Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: Insights from the ARTESiA trial

Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness

Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort

Catheter ablation for atrial fibrillation in patients with heart failure with reduced versus preserved ejection fraction; a systematic review and meta-analysis

VISION Cardiac Surgery Post-operative AF

Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT

Incidence and risk of short episodes of atrial fibrillation detected with 14 days of continuous electrocardiographic monitoring

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis

ESC 365 is supported by